Plain-English translation of NCT07275151 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Atrial Fibrillation research guide →This trial is testing a new software tool called PFAnalyzer that helps doctors measure whether a newer ablation energy source—pulsed field ablation (PFA)—has successfully treated atrial fibrillation. The software analyzes electrical signals recorded during your ablation procedure to help doctors understand if the treatment worked. This is an observational study, meaning researchers will collect data during your standard procedure but won't use the software results to guide your care.
Pulsed field ablation is a newer, safer way to treat atrial fibrillation because it doesn't damage nearby structures like the esophagus or nerves, but the catheters used with this treatment don't give doctors the same feedback they're used to receiving. This study is designed to develop a new tool that gives doctors better information about whether the treatment is working.
You likely qualify if…
You likely don't qualify if…
You will undergo your standard ablation procedure as planned by your doctor. During the procedure, the new software will quietly record electrical signals from the ablation catheters—this adds no extra time or discomfort to your care. After your procedure is finished, researchers will analyze the software data offline to see if it helps predict treatment success. Your doctor will follow the hospital's normal care plan throughout, and the software results won't change how your procedure is performed.
AI-generated summary from trial data · Aug 6, 2026 · Not medical advice
United States